Paul Mahon
Net worth: 24 M $ as of 30/06/2026
Net worth: 24 M $ as of 30/06/2026
Paul A. Mahon is Co-Managing Director at Unither Therapeutik GmbH.
Mr. Mahon is Secretary, Executive VP & General Counsel at United Therapeutics Corp.
since 2003.
Mr. Mahon is Secretary, Executive VP & General Counsel at Miromatrix Medical, Inc. since 2023.
Mr. Mahon is partner at Hyperion Equity Partners Ltd. Mr. Mahon was Director at SteadyMed Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/07/2026 | 45,172 ( 0.11% ) | 24 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | General Counsel | 26/06/1996 |
| MIROMATRIX MEDICAL INC. | General Counsel | 11/12/2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| STEADYMED LTD | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions